XML 19 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Cash flows from operating activities:          
Net loss $ (8,377) $ (2,737) $ (13,764) $ (7,522)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization     499 454  
Share-based compensation     302 11  
Change in fair value of warrant liability 5,549   5,549    
Deferred rent     (1) 3  
Changes in operating assets and liabilities:          
Prepaid expenses and deferred IPO costs and other assets     (151) (249)  
Accounts payable     999 334  
Accrued expenses and other current liabilities     495 (52)  
Net cash used in operating activities     (6,072) (7,021)  
Cash flows from investing activities:          
Purchases of property and equipment     (540) (166)  
Net cash used in investing activities     (540) (166)  
Cash flows from financing activities:          
Proceeds from convertible promissory notes       6,800  
Proceeds from exercise of stock options     7    
Proceeds from long-term debt     500    
Proceeds from the sale of Series A convertible preferred stock     11,046    
Payment of IPO costs     (309)    
Payment of Series A convertible preferred stock issuance costs     (27)    
Payment of equipment loan payable     (165) (183)  
Payment of capital lease obligations     (239) (272)  
Net cash provided by financing activities     10,813 6,345  
Net increase (decrease) in cash and restricted cash     4,201 (842)  
Cash and restricted cash at beginning of period     2,643 1,702 $ 1,702
Cash and restricted cash at end of period $ 6,844 $ 860 6,844 860 $ 2,643
Supplemental disclosures of cash flow information:          
Cash paid for interest     27 $ 72  
Supplemental disclosures of non-cash investing and financing activities:          
Fair value of liability-classified warrants issued in connection with Series A convertible preferred stock     1,522    
Series A convertible preferred stock and warrants issuance costs in accounts payable     22    
IPO costs included in accounts payable and accrued expenses and other current liabilities     $ 2,221